Chinese publicly-traded steroid biotechnology company Shandong Sito Biotechnology has agreed to pay 458.1 million yuan ($62.7 million) for a 60% stake in domestic pharmaceutical firm Yingu Pharmacy.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
